Cargando…
Biomarkers in heart failure with preserved ejection fraction
Biomarkers are widely used and studied in heart failure. Most studies have described the utility and performance of biomarkers in sub-studies of randomised clinical trials, where the vast majority of the patients suffered from heart failure with reduced ejection fraction (HFrEF), and not with preser...
Autores principales: | Meijers, W. C., van der Velde, A. R., de Boer, R. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796059/ https://www.ncbi.nlm.nih.gov/pubmed/26942916 http://dx.doi.org/10.1007/s12471-016-0817-7 |
Ejemplares similares
-
Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016) -
Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
por: Tromp, Jasper, et al.
Publicado: (2017) -
Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013) -
Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022) -
Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)